Laurus Labs expands stake in Immunoadoptive Cell Therapy for Rs.80cr
Hyderabad-based pharmaceutical company Laurus Labs has announced a significant investment in Immunoadoptive Cell Therapy (lmmunoACT), an advanced cell and gene therapy firm. The deal, valued at INR 80 crores, will increase Laurus Labs’ stake in ImmunoACT to 33.86% on a fully diluted basis. This strategic move is expected to provide ImmunoACT with the necessary capital […]